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RIF1 promotes replication fork protection and
efﬁcient restart to maintain genome stability
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Homologous recombination (HR) and Fanconi Anemia (FA) pathway proteins in addition to
their DNA repair functions, limit nuclease-mediated processing of stalled replication forks.
However, the mechanism by which replication fork degradation results in genome instability
is poorly understood. Here, we identify RIF1, a non-homologous end joining (NHEJ) factor, to
be enriched at stalled replication forks. Rif1 knockout cells are proﬁcient for recombination,
but displayed degradation of reversed forks, which depends on DNA2 nuclease activity.
Notably, RIF1-mediated protection of replication forks is independent of its function in NHEJ,
but depends on its interaction with Protein Phosphatase 1. RIF1 deﬁciency delays fork restart
and results in exposure of under-replicated DNA, which is the precursor of subsequent
genomic instability. Our data implicate RIF1 to be an essential factor for replication fork
protection, and uncover the mechanisms by which unprotected DNA replication forks can
lead to genome instability in recombination-proﬁcient conditions.
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Proteins involved in the HR and FA pathways like BRCA1/2and FANCD2 have been associated with repair ofreplication-associated DNA damage1,2. Additionally, HR
and FA factors protect DNA replication forks from extensive
MRE11 nuclease-mediated degradation, preventing genome
instability3,4. This function is clinically relevant as fork protection
was found to induce chemoresistance in BRCA2-defective cells5,6.
Another parallel pathway in the processing of stalled replication
forks has been identiﬁed, involving the DNA2 nuclease7,8.
Recently, replication fork reversal was shown to be required for
effective fork degradation in BRCA2-deﬁcient cells, with the
“regressed arm” being the access point for MRE11-mediated
processing9–12. Although fork reversal is a stabilizing structure for
stalled replication forks13–16, degradation of regressed forks
results in genome instability9–12. However, the mechanisms that
regulate fork degradation-mediated genome instability remain
poorly understood.
Mammalian Rap1-interacting factor 1 (RIF1) has multiple
functions, including mediating NHEJ at double strand breaks
(DSBs), regulation of replication origin timing, and resolution of
catenanes17–25. In the process of DSB repair via NHEJ, RIF1 is a
crucial interactor of 53BP117,19–21,25,26 and interacts with the
N-terminal SQ/TQ sites of 53BP126. Loss of RIF1 also results in
resistance to PARP inhibitor treatment signifying its clinical
relevance17,20,21.
RIF1 has also been implicated in the control of replication timing
in mammalian cells18, mediated through its interaction with Protein
Phosphatase 1 (PP1)22,24. Interestingly, Rif1-deﬁcient mice are
embryonic lethal, suggesting that RIF1 could be involved in the
tolerance of high levels of replicative stress encountered during
proliferation of stem cells27,28.
Here, we show a novel role for RIF1 in the protection of
reversed replication forks from DNA2-mediated degradation.
Furthermore, the C-terminal domain of RIF1—responsible for
binding both protein phosphatase 1 as well as cruciform DNA
structures—is essential for protecting reversed forks from
degradation. Finally, we provide evidence that degradation of
reversed forks is linked to defective replication restart in RIF1-
deﬁcient cells, resulting in the accumulation of under-replicated
DNA and subsequent genome instability.
Results
RIF1 is recruited to stalled DNA replication forks. To identify
novel factors enriched at stalled replication forks, we utilized
iPOND (isolation of proteins on nascent DNA) coupled with
SILAC (stable isotope labeling of amino acids in cell culture)-based
quantitative mass-spectrometry29,30. Mouse embryonic stem cells
were treated with hydroxyurea (HU) to stall DNA replication forks
and subsequently subjected to quantitative mass-spectrometry to
analyze the proteomes associated with the replication forks (Fig. 1a
and Supplementary Data 1). Seven-hundred twenty-one proteins
were identiﬁed commonly between two independent experiments
(Supplementary Fig. 1a). We identiﬁed RIF1 among 44 proteins,
which showed >2-fold enrichment upon HU treatment (Fig. 1b
and Supplementary Data 1). Consistent with previous reports, we
also observed over two-fold increase in replication stress response
proteins, including RAD51 and RPA2 (Fig. 1c and Supplementary
Data 1)29,30. Whereas core components of the replicative helicase,
including MCM2-7, largely remained unchanged at time of early
replication stress, PCNA enrichment decreased at stalled replica-
tion forks, as reported previously30 (Fig. 1c).
To further verify the recruitment of RIF1 to stalled forks, we
performed immunoﬂuorescence analysis to measure localization
of RIF1 at sites of DNA replication. Wild type (WT) mouse
embryonic ﬁbroblasts (MEFs) were incubated with EdU, and
localization of RIF1 to sites of EdU incorporation was measured
in the presence or absence of HU treatment (Fig. 1d).
Approximately 50% of the WT cells in non-treated condition
(NT) showed EdU incorporation, (Fig. 1d, e). Only a small
fraction of EdU-positive WT cells in non-treated cells were
positive for RIF1 foci. By contrast, upon HU treatment,
approximately 80% of the EdU-positive cells showed EdU co-
localization with RIF1 (Fig. 1d, e and Supplementary Fig. 1c). To
verify that EdU and RIF1 co-localization upon HU treatment
indeed occurred at stalled forks, we performed proximity ligation-
based assays (PLA) to detect RIF1 binding to replicated DNA12.
WT cells treated with HU displayed a signiﬁcant increase in PLA
signals per cell. However, the total percentage of PLA-positive
cells (signifying the replicating population) did not increase
signiﬁcantly (Supplementary Fig. 1d), suggesting that RIF1 is
recruited to stalled DNA replication forks.
Since RIF1 localization to sites of DSBs depends on
53BP117,19–21,25,26 (Supplementary Fig. 1b, e), we tested if
localization of RIF1 to stalled replication forks also required
53BP1. Interestingly, upon HU treatment 53bp1−/− MEFs
showed similar levels of RIF1-EdU co-localization as WT cells
(Fig. 1d, e and Supplementary Fig. 1b, c). Finally, we tested
whether 53BP1 also localized to sites of DNA stalled forks upon
HU treatments. In WT MEFs we observed 53BP1 foci in a low
percentage of cells, but these foci did not co-localize with EdU
(Supplementary Fig. 1f). Furthermore, HU treatments did not
signiﬁcantly increase the percentage of 53BP1-positive cells
(Supplementary Fig. 1f), suggesting that RIF1 is enriched at
stalled replication forks, independently of 53BP1.
RIF1 protects reversed DNA replication forks. To explore the
role of RIF1 during unperturbed DNA replication, we monitored
the frequency of replicating cells by incorporation of EdU by ﬂow
cytometry (Supplementary Fig. 2a–d). WT and Rif1−/− cells
showed similar percentages and intensities of EdU staining
(Supplementary Fig. 2b–d). Additionally, we analyzed progres-
sion rates of individual replication forks in WT and Rif1−/− cells
by DNA ﬁber assay. We sequentially labeled cells with CldU (red)
and IdU (green), followed by tract length analysis (Fig. 2a and
Supplementary Fig. 7a). WT and Rif1−/− cells revealed no sig-
niﬁcant difference in tract lengths, again suggesting that RIF1 is
not essential for unperturbed DNA replication (Fig. 2a).
Next, we tested if RIF1 was involved in stabilizing DNA
replication forks under stressed conditions. WT and Rif1−/−
MEFs were sequentially labeled with CldU and IdU. On-going
replication forks were then stalled with HU (Fig. 2b). The relative
shortening of the IdU tract after HU treatment served as a
measure of fork degradation (Fig. 2b). Upon HU treatment,
WT cells showed tract lengths similar to non-treated cells with
mean ratio close to 1 (Fig. 2b). Contrastingly, RIF1-deﬁcient cells
displayed a signiﬁcant reduction in the IdU tract lengths (Fig. 2b
and Supplementary Fig. 7b). Human RIF1 knock-out HAP1 cells
(RIF1-KO)23, also revealed a similar trend as observed in Rif1−/−
MEFs (Fig. 2c and Supplementary Figs. 2e and 7c). This suggests
that RIF1 is essential for protection of replication forks
from degradation (Fig. 2b, c). Recently, 53BP1 deﬁciency in
B-lymphocytes was demonstrated to cause degradation of nascent
strands31. Since RIF1 interacts with 53BP1 for NHEJ, we tested
whether protection of nascent strands by RIF1 could be
dependent on this interaction. Analysis of 2 different clones of
53bp1−/−MEFs did not show fork degradation upon HU
treatment. This suggests that in our experimental setup, the role
of RIF1 in replication fork protection is independent of 53BP1
(Fig. 2d and Supplementary Fig. 7d).
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Fig. 1 RIF1 is recruited to the stalled replication forks. a Schematic representation of iPOND experiment. b Volcano plot showing the results for average
fold-change to identify signiﬁcantly upregulated proteins upon HU treatment based on H:L ratio in the SILAC experiment. The x-axis ('2Log Difference
HU/NT) represents the fold upregulation. Data points in blue represent proteins that are upregulated >2-fold; RIF1 is indicated in red. c Bar graph
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d Representative micrographs showing co-localization of RIF1 (green) to sites of DNA replication as marked by EdU (red) in the presence or absence
of HU in WT and 53bp1−/− cells. Nucleus was stained with DAPI (blue). e Quantitation of d showing the percentage of cells, which show co-
localization between EdU and RIF1(error bars represent standard deviation)
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Fork degradation has been associated with loss of HR factors3,4.
We, therefore, tested if loss of RIF1 also resulted in HR defects.
Localization of the RAD51 recombinase to sites of DNA DSBs has
been shown to be a reliable readout for functional HR32.
Upon ionizing irradiation, Rif1−/− MEFs were proﬁcient
in forming RAD51 foci (Supplementary Fig. 3a, b). Additionally,
we monitored HR efﬁciency using the DR-GFP reporter33.
Consistent with earlier reports20,34,35, Rif1−/− MEFs did not
show a signiﬁcant difference in HR frequencies when compared
to WT cells (Supplementary Fig. 3c). Finally, we tested the ability
of RIF1-deﬁcient cells to form sister chromatid exchanges (SCEs)
in the presence or absence of HU or cisplatin. Treatments with
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either HU or cisplatin signiﬁcantly increased the number of SCEs
in both WT and Rif1−/−cells. However, no signiﬁcant differences
in SCEs were observed between WT and Rif1−/− cells
(Supplementary Fig. 3d–e). Taken together, these data suggest
that loss of RIF1 does not result in defective HR.
DNA replication stress results in fork reversal14. Recent reports
have identiﬁed reversed forks to be the substrate for nascent stand
degradation in the absence of BRCA29–12. We, therefore,
hypothesized that RIF1 -like BRCA2- could be involved in the
protection of reversed forks. To assess replication fork architecture
in WT and Rif1−/− cells, we visualized replication intermediates
formed in vivo using electron microscopy (EM)36. HU treatment of
WT MEFs resulted in a high percentage of reversed replication
forks (Fig. 2e, f and Supplementary Data 3). In contrast, HU-
treated RIF1-deﬁcient cells showed a signiﬁcantly lower frequency
of fork reversal (Fig. 2f and Supplementary Data 3). These data
suggest that RIF1 could either be involved in mediating fork
reversal or in protecting reversed forks.
RAD51 has been shown to be essential for mediating fork
reversal11,37,38. RAD51 downregulation rescues fork degradation
in BRCA2-deﬁcient cells, suggesting that unprotected reversed
forks are the substrates for degradation10,11,39. However,
stabilization of RAD51 on the reversed forks is also important
for protection of reversed forks40. To test if RIF1 is involved in
fork reversal, we downregulated RAD51 in WT and RIF1-
deﬁcient MEFs and tested for fork degradation (Fig. 2g and
Supplementary Fig. 3f). Near-complete downregulation of
RAD51 in WT cells did not induce fork degradation in
WT cells (Fig. 2g)10,11,39. However, RAD51 downregulation in
Rif1−/− cells signiﬁcantly rescued fork degradation, suggesting
that RIF1 is required for fork protection but not for reversal of
forks (Fig. 2g and Supplementary Fig. 3f, 7e). Consistently, our
EM analysis showed that knockdown of RAD51 in WT cells
resulted in almost complete abolishment of fork reversal upon
HU treatments (Fig. 2h and Supplementary Data 3)11,37,38.
However, this decrease in fork reversal was not further affected
by RIF1 inactivation (Fig. 2h and Supplementary Data 3). To
subsequently test if RIF1 acts epistatic to RAD51 in protecting
reversed forks, we partially downregulated RAD51 in WT and
Rif1−/− cells and assessed fork degradation (Supplementary
Figs. 3g, h and 7f). Partial downregulation of RAD51 resulted in
fork degradation in WT cells, but did not result in aggravated
degradation observed upon RIF1-deﬁciency alone, suggesting
that RIF1 could also be involved in the stabilization of RAD51
on the reversed arm (Supplementary Figs. 3h and 7f). Taken
together, these data strongly suggest that RAD51 acts upstream
of RIF1 in fork reversal and that RIF1 could be involved in the
protection of reversed forks, rather than the process of fork
reversal itself.
Fork degradation in RIF1-deﬁcient cells mediated by DNA2.
Since MRE11 has been implicated in mediating replication fork
degradation3,4, we tested if MRE11 is also responsible for fork
degradation upon RIF1- deﬁciency. We downregulated MRE11 in
WT and Rif1−/− MEFs (Fig. 3a) and measured fork degradation.
Downregulation of MRE11 in RIF1-deﬁcient cells resulted in a
partial but signiﬁcant rescue of fork degradation (Fig. 3b and
Supplementary Fig. 7g). Since partial rescue of fork degradation
could result from residual MRE11 activity, we treated cells with
the MRE11 inhibitor Mirin41. Mirin treatment failed to com-
pletely rescue the fork degradation phenotype in Rif1−/− MEFs,
again suggesting that MRE11 is not the main nuclease involved in
degradation of replication forks in Rif1−/− cells (Supplementary
Fig. 4a and 7h). DNA2 nuclease has been implicated in the restart
of reversed replication forks37 and the uncontrolled degradation
of stalled replication forks7,8. Therefore, we tested if DNA2 was
involved in the degradation of replication forks in Rif1−/− MEFs.
Downregulation of DNA2 completely rescued the fork degrada-
tion in Rif1−/− MEFs (Fig. 3a, b). We next analyzed the invol-
vement of DNA2 in fork degradation in RIF1-KO HAP1 cells,
using the DNA2 inhibitor NSC-105808 (DNA2i)42. Pretreatment
of RIF1-KO cells with DNA2i signiﬁcantly rescued the degrada-
tion of nascent strands (Fig. 3c), and no additional rescue was
observed upon combined Mirin and DNA2i treatments (Fig. 3c
and Supplementary Fig. 7i). A dependency on DNA2 for fork
degradation was also conﬁrmed in Rif1−/− MEFs, using either
Mirin, DNA2i or both (Supplementary Figs. 4a and 7h). To verify
the context speciﬁcity for DNA2, we pretreated Brca1−/− MEFs
with either Mirin, DNA2i or both and assessed the rescue of fork
degradation. While Mirin treatment rescued fork degradation as
expected (Supplementary Figs. 4b and 7j), DNA2i treatment only
partially rescued fork degradation in Brca1−/− cells. Additionally,
combined inhibition of MRE11 and DNA2 in Brca1−/− cells did
not show any additive effect (Supplementary Figs. 4b and 7j),
suggesting that DNA2 is the main nuclease driving fork degra-
dation in RIF1-deﬁcient cells.
Next, to test if DNA2 inhibition could rescue formation of
reversed forks upon RIF1-deﬁciency, cells were treated with HU
in the presence or absence of DNA2i, and the frequencies of
reversed forks were analyzed. As observed earlier, Rif1−/− MEFs
treated with HU displayed a signiﬁcantly reduced frequencies
of reversed forks. Strikingly, treatment with DNA2i and HU in
Rif1−/− cells signiﬁcantly rescued fork reversal (Fig. 3d and
Fig. 2 Protection of reversed forks from degradation by RIF1. a Top panel: schematics of experimental conditions for fork progression in WT and Rif1−/−
MEFs. Cells were labeled with CldU (red) followed by IdU (green) as indicated. Representative DNA ﬁbers for progression in WT and Rif1−/− MEFs are
shown below the schematic. Progression was measured by tract lengths of CldU (red) and IdU (green) in micrometers (μM). b Top panel: schematic for
labeling cells in fork degradation assay. Representative pictures of normal and degraded fork are shown below the schematic. Cells were labeled with CldU
followed by IdU and then subjected to replication stress with 4 mM HU for 3 h. Ratio of IdU to CldU tract length was plotted as readout for fork
degradation. c, d Fork degradation assay in WT and RIF1-KO HAP1 cells (c) and between two different clones of WT, Rif1−/−, and 53bp1−/− MEF cell line
(d). Experimental conditions were similar as in b. e Representative electron micrographs of normal fork (left) and reversed replication fork (right) observed
on treatment with HU. The black arrow pointing to four-way junction at the replication fork indicates fork reversal (P, Parental, D, Daughter strand, R,
Reversed arm). f Percentage of fork reversal in WT and Rif1−/− MEFs treated with or without HU (4mM) for 3 h. Numbers of analyzed molecules are
indicated in parentheses. g WT and Rif1−/− MEFs were transfected with siRad51 (100 nmols, 48 h) followed by labeling and treatment with 4mM HU for
3 h. Fork degradation was determined in the presence and absence of RAD51. h Fork reversal frequencies observed with and without depletion of RAD51 in
WT and Rif1−/− MEFs under HU treatment. Numbers of analyzed molecules are indicated within parenthesis. Red bars in a, b, c, d, and g represent mean
values from 125 ﬁbers from each genotype under each condition. P-values were derived from Kruskal–Wallis ANOVA with Benjamini Hochberg (BH) post
test except in c, where Mann–Whitney was used and in f and h, where unpaired t-test was done (ns, non-signiﬁcant, ****P < 0.0001). All experiments were
repeated three times with similar outcomes (Supplementary Data 2 and Supplementary Fig. 7a–e)
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Supplementary Data 3). Altogether, these data show that RIF1 is
responsible for protecting reversed replication forks from DNA2-
mediated degradation.
C-terminal region of RIF1 is essential for fork protection.
Mammalian RIF1 has two conserved regions at its termini20. The
N-terminus consists of HEAT-like α-helical repeats (HEAT-
repeats) and is required for Rif1 recruitment to sites of DSBs20.
The C-terminal domain (CTD) of RIF1 consists of three sub-
domains (CI, CII and CIII) and confers in vitro DNA binding
activity, preferentially to cruciform structures43. Mammalian
RIF1 also contains two PP1 interaction motifs, which are
responsible for the control of replication timing24,40,43.
To test which domain of RIF1 is responsible for protection of
reversed replication forks, we generated truncation constructs
from a human full-length RIF1 construct (hRIF1-FL)20. Deletion
constructs were generated for the HEAT domain (Del-HEAT),
CTD domain (Del-CTD), CI domain (Del-CI), and CII domain
(Del-CII) (Fig. 4a). These constructs were then transfected into
Rif1−/− MEFs and checked for their expression levels (Fig. 4b).
Complementation with hRIF1-FL and Del-HEAT signiﬁcantly
rescued the fork degradation observed in Rif1−/− MEFs (Fig. 4c).
In contrast, expression of RIF1 deletion mutants with either the
CI, CII domains or the whole CTD failed to rescue the fork
degradation in RIF1-deﬁcient cells (Fig. 4c and Supplementary
Fig. 8a). Furthermore, complementation of Rif1−/− MEFs with
either hRIF1-FL or Del-HEAT constructs resulted in a ~2-fold
increased fork reversal frequency when compared with Rif1−/−
MEFs (Fig. 4d and Supplementary Data 3). In contrast, Rif1−/−
MEFs with either Del-CI or Del-CII failed to restore fork reversal
frequencies in these cells (Fig. 4d). These data suggest that the CI
and CII domains of RIF1, which contain interaction motifs for
PP1 and have DNA cruciform binding properties, are essential for
protection of reversed forks.
To directly test the involvement of PP1 in replication fork
protection, we depleted PP1 in WT and Rif1−/− MEFs and
assessed fork degradation (Supplementary Fig. 4c). Interestingly,
depletion of PP1 in WT cells resulted in signiﬁcant fork
degradation upon HU treatments, which was epistatic with
RIF1 (Fig. 4e and Supplementary Fig. 8b). Furthermore,
pretreatment of WT and Rif1−/− MEFs with the selective PP1
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Fig. 3 DNA2 drives reversed fork degradation in RIF1-deﬁcient cells. aWestern blot analysis for the downregulation of MRE11 and DNA2 in WT and Rif1−/−
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inhibitor tautomycetin (PP1i)44,45 resulted in similar degradation
proﬁles as observed upon knockdown of PP1 (Supplementary
Figs. 4d and 8c). HU treatment after PP1 inhibition in WT cells
also resulted in a signiﬁcant decrease of fork reversal frequencies
(Fig. 4f and Supplementary Data 3). PP1i treatment in RIF1-
deﬁcient cells did not further decrease the amount of fork reversal
to levels observed in either Rif1−/− cells or WT cells treated PP1i
(Fig. 4f), suggesting that RIF1 and PP1 are epistatic for preventing
the degradation of reversed forks (Fig. 4e, f, Supplementary
Fig. 8b, c and Supplementary Data 3).
DNA2 phosphorylation was shown to be important for
recruitment to DSBs in yeast46. We, therefore, hypothesized that
access of DNA2 to forks upon replication stress could be
controlled by PP1 in a phosphorylation-dependent manner. To
test this hypothesis, we immunoprecipitated DNA2 from nuclear
extracts of WT or Rif1−/− MEFs treated with either HU or HU
and PP1i. The immunoprecipitated DNA2 was then probed for
phosphorylation status using the phospho-S/TQ motif antibody.
Treatment with HU slightly increased the levels of DNA2
phosphorylation in WT cells when compared to untreated cells
(Fig. 4g). PP1 inhibition markedly increased the phosphorylation
levels of DNA2 upon HU treatment (Fig. 4g). Additionally,
DNA2 phosphorylation levels in RIF1-deﬁcient cells upon HU
treatments were observed to be similar to WT cells upon PP1
inhibition. The DNA2 phosphorylation status was not further
increased upon inhibition of PP1 in RIF1-deﬁcient cells upon HU
treatment, suggesting that RIF1-PP1 interaction controls DNA2
phosphorylation levels upon replicative stress (Fig. 4g).
RIF1 deﬁciency results in defective fork restart. Nascent strand
degradation has been linked to increased genome instability4. We,
therefore, tested if fork degradation in RIF1-deﬁcient cells induces
immediate induction of DSBs. We performed pulsed-ﬁeld gel
electrophoresis (PFGE) analysis16 where we did not observe a
signiﬁcant difference between WT and Rif1−/−MEFs (Fig. 5a, b).
Treatment with HU resulted in a marginal but non-signiﬁcant
increase of DSBs both in WT and Rif1−/− cells, when compared
to their non-treated counterparts (Fig. 5a, b). These low levels of
DSBs observed in RIF1-deﬁcient cells were not suggestive of fork
collapse into DSBs upon degradation, a phenomenon that was
observed on the entire population of active forks (3000–12,000
per cell)47 (Fig. 5b).
We next tested if fork degradation resulted in genome
instability in WT and Rif1−/− MEFs treated with replication
stress-inducing agents HU, cisplatin, and Camptothecin (CPT)
(Fig. 5c, d and Supplementary Fig. 5a) by metaphase spreads.
Untreated Rif1−/− cells did not show a signiﬁcant increase in
aberrant chromosomes (Fig. 5c, d and Supplementary Fig. 5a).
However, upon HU, cisplatin or CPT treatment, Rif1−/− MEFs
displayed signiﬁcantly increased aberrations when compared to
their WT counterparts (Fig. 5c, d and Supplementary Fig. 5a).
Furthermore, consistent with previous data27,48, clonogenic
survival assays performed in WT and Rif1−/− MEFs showed
that RIF1 deﬁciency also resulted in increased sensitivity to HU,
cisplatin or CPT (Fig. 5e, f and Supplementary Fig. 5b). These
data show that although fork degradation does not result in
immediate replication fork collapse, it results in increased
genome instability and sensitivity to replication stress.
We hypothesized that the increased genome instability in
RIF1-deﬁcient cells could arise from defective restart of stalled
replication forks. To test this, we performed a fork restart assay,
in which cells were labeled with CldU followed by HU treatment
to stall the forks and then released into IdU (Fig. 5g). However,
WT and RIF1-deﬁcient cells did not reveal a signiﬁcant difference
between stalled versus restarted forks, suggesting that the
majority of forks were restarted (Supplementary Fig. 5c). Further
analysis of individual tract lengths revealed that restarted forks
from Rif1−/− cells showed signiﬁcantly shorter IdU tracts,
suggestive of a delayed restart in these cells (Fig. 5h and
Supplementary Fig. 8d). A similar trend of delayed fork restart
was also observed in RIF1-KO HAP1 cells (Supplementary
Figs. 5d and 8e). Shorter inter-origin distances could also account
for smaller IdU labels in RIF1-deﬁcient cells upon restart. To test
this, we allowed the forks to restart after HU treatments for
multiple time points ranging from 15′ to 60′. A signiﬁcant
decrease in the percentage of restarted forks was observed at early
time points after release (15′ and 30′) in Rif1−/− cells, but not at
later time points (45′ and 60′) (Supplementary Fig. 5e). However,
the CldU tract lengths at 30′, 45′, and 1 h show signiﬁcant shorter
tracts in RIF1-deﬁcient cells, suggesting that the shorter tracts
could be due to delayed restart in these cells (Supplementary
Figs. 5f and 8f).
Since 53BP1 was recently implicated in replication fork
restart49, we wondered if the restart defect observed upon RIF1
inactivation is epistatic with 53BP1. To this end, we used
53BP115A MEFs, which lack 15S/TQ phosphorylation sites within
53BP1 essential for RIF1 binding26. 53BP115A cells did not
display a defect, suggesting that RIF1 and 53BP1-mediated restart
is differentially regulated (Supplementary Figs. 5g and 8g). These
data suggested that the genome instability and sensitivity
observed in RIF1-deﬁcient cells could be a result of defective
restart in these cells.
Restart delay results in genome instability. To explore whether
fork restart defects in RIF1-deﬁcient cells cause genome
instability, we tested directly if forks restarted after HU treat-
ments resulted in formation of DSBs. WT and Rif1−/− MEFs
were assayed for formation of DSBs by PFGE at 15 h after release
from HU-induced fork stalling. As observed previously, HU
treatment in either WT or RIF1-deﬁcient cells did not cause a
signiﬁcant change in DSBs frequency (Figs. 5a, b and 6a, b).
However, Rif1−/− cells displayed a signiﬁcant increase of DSBs
compared to WT cells (Fig. 6a, b), which could be a result of
decreased repair of DSBs after release. Since RIF1-deﬁcient do not
have a HR defect, we also tested if these cells show defective
NHEJ. Using a reporter-based NHEJ assay50, we found a sig-
niﬁcant decrease in NHEJ levels in RIF1-deﬁcient cells when
compared to WT cells, consistent with published evidence17
(Supplementary Fig. 6a). Since the 53BP1-RIF1 axis is responsible
for NHEJ repair, we next tested if 53BP1 deﬁciency also resulted
in genome instability upon replication stress. In contrast to RIF1-
deﬁcient cells, which showed high levels of genome instability,
53BP1 deﬁciency did not result in signiﬁcant chromosomal
aberrations upon either HU or cisplatin treatments (Supple-
mentary Fig. 6b). Taken together, these data suggest that defective
NHEJ-mediated repair could be involved in increased DSB for-
mation in RIF1-deﬁcient cells upon restart. However, this cannot
completely account for the increased genome instability observed
in RIF1-deﬁcient cells, as 53bp1−/−MEFs did not show increased
levels of genome instability upon induction of replication stress.
To further test if the delayed restart resulted in increased single-
stranded DNA (ssDNA) levels in these cells, we analyzed RPA2, a
surrogate for ssDNA, by ﬂow cytometry. Upon HU treatment, the
replication-associated RPA2 signals were markedly enhanced in
both Rif1−/− and WT cells (Supplementary Fig. 6c, d). At 5 h after
release from a HU-mediated block, slightly reduced but still
signiﬁcantly higher levels of RPA were observed in both the cell
types (Supplementary Fig. 6c, d). However, at 15 h after HU
release, WT cells showed low RPA levels, along with normal cell
cycle proﬁles. In contrast, Rif1−/− cells displayed an accumulation
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of cells in late S/G2 with signiﬁcantly higher percentages of RPA2-
positive cells (Supplementary Fig. 6c–e). To subsequently test if
RIF1-deﬁcient cells entered mitosis with high levels of under-
replicated DNA, we performed co-staining for phospho-histone
H3 in combination with RPA2 using the same experimental
conditions as in Supplementary Fig. 6c. However, we did not
observe any signiﬁcant differences in phospho-histone H3-positive
cells between the two genotypes (Supplementary Fig. 6f), suggest-
ing that upon restart, RIF1-deﬁcient cells expose increased
amounts of ssDNA, which causes accumulation in late S/G2
phase of the cell cycle.
We speculated that the increased levels of ssDNA in RIF1-
deﬁcient cells could be a result of under-replicated DNA during the
restart process. To test this hypothesis, we performed EM analysis
of restarted forks. Interestingly, we observed a signiﬁcant increase
in replication intermediates with high levels of ssDNA at forks in
RIF1-deﬁcient cells when compared to WT cells (Fig. 6c, e).
Furthermore, a signiﬁcant increase was observed in ssDNA gaps
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behind forks in Rif1−/− cells (Fig. 6d, f). To test if ssDNA regions
observed in RIF1-deﬁcient cells were a result of the fork
degradation process, we inhibited DNA2 in WT and Rif1−/− cells
before release from HU block. Interestingly, DNA2 inhibition in
RIF1-deﬁcient cells signiﬁcantly reduced both the ssDNA regions
at the forks and the gaps behind the forks in RIF1-deﬁcient cells
(Fig. 6e, f). These data suggest that the increased ssDNA regions
observed at and behind the replication forks in RIF1-deﬁcient cells
could be a consequence of defective restart caused due to fork
degradation. To verify this hypothesis, we performed a fork restart
assay, in which WT and Rif1−/− cells were pre-incubated with
DNA2i during HU treatment to prevent fork degradation. Forks
were then allowed to restart, and subsequently assessed for IdU
tract length (Fig. 6g). DNA2 inhibition during HU treatment
completely rescued the restart delay in RIF1-deﬁcient cells (Fig. 6g
and Supplementary Fig. 8h). Furthermore, complementation of
Rif1−/− MEFs with hRIF1-FL or the Del-HEAT mutant rescued
the restart defect in RIF1-deﬁcient cells (Fig. 6h and Supplemen-
tary Fig. 8i). However, complementation with either Del-CI or Del-
CII did not restore the restart defect upon RIF1 deﬁciency, in good
agreement with our earlier data that these domains are essential for
protection of reversed forks (Figs. 6h and 4c, d). These data further
strengthen the concept that protection of reversed forks from
degradation is linked to efﬁcient fork restart.
Finally, we tested if allowing efﬁcient restart in RIF1-deﬁcient
cells could rescue the observed sensitivity to replication stress-
inducing agents. Rif1−/− MEFs were complemented with either
hRIF1-FL, Del-HEAT, Del-CI or Del-CII, and treated with either
HU or cisplatin. Complementation of Rif1−/− with either hRIF1-
FL or Del-HEAT signiﬁcantly rescued the sensitivity of cells to
replication stress, in line with our molecular data (Fig. 6i and
Supplementary Fig. 6g). In contrast, complementation with Del-
CI or Del-CII failed to rescue the sensitivity of RIF1-deﬁcient cells
(Fig. 6i and Supplementary Fig. 6g). These results strongly suggest
that replication fork protection and subsequent efﬁcient fork
restart are physiologically important processes for cellular
survival in situations of replication stress.
Discussion
Our ﬁndings identify a novel role of RIF1 in the protection of
nascent strands, which underpins how degradation of reversed
replication forks can result in genome instability. Replication fork
degradation results in genome instability in HR- and FA-defective
cells3,4. However, it remained poorly understood how degrada-
tion of reversed forks results in genome instability.
We show that RIF1 associates with stalled forks and protects
them from DNA2-mediated degradation, which is independent of
its known interaction with 53BP117,19–21,25,26 and thus NHEJ
(Figs. 1–3). We further show that loss of Rif1 results in de-
protection of reversed forks, resulting in extensive fork
degradation (Fig. 2b–f). Importantly, RIF1 was found to act
downstream of RAD51, which is involved in fork reversal and in
protection of regressed arms (Fig. 2g, h).
Recent studies have also implicated reversed replication forks to
be a substrate for MRE11 nuclease action in BRCA2-deﬁcient cells.
Other nucleases, including DNA2, MUS81, and EXO1, have also
been proposed to mediate fork degradation7,8,51. Degradation of
reversed forks upon RIF1 deﬁciency appears to be primarily
dependent on DNA2 activity, with a partial requirement of MRE11.
These ﬁndings suggest that whereas MRE11 can partially access the
reversed arm upon RIF1 deﬁciency, DNA2 is the main nuclease in
the degradation process in these conditions (Figs. 2 and 3).
Our data also show that the C-terminal region of RIF1 (con-
sisting of sub-domains CI, CII, and CIII) is essential for protecting
reversed forks from degradation (Fig. 4c, d). The CI region has two
conserved binding sites for PP1α40, CII region binds to cruciform
DNA structures43, while the complete C-terminal domain is
responsible for BLM binding48. Our data demonstrate that the CII
domain of RIF1, which binds to cruciform structures, is critical for
the protection of reversed forks upon replication stress (Fig. 4c, d).
One possibility could be that RIF1 binds to reversed forks, which
represent cruciform structures in vivo upon replication stress, and
physically protect such forks. Another possibility involves the
requirement of both the functions of CI and CII domains of RIF1
in fork protection, as also suggested by our data (Fig. 4c–e). In this
scenario, binding of the CII domain to reversed forks could then
recruit PP1 through the CI domain to the forks. This recruitment
of PP1 could post-translationally restrict DNA2 nuclease activity
though de-phosphorylation of DNA2 in the vicinity of forks,
thereby protecting them from degradation. In line with this
hypothesis, we show that downregulation/ inhibition of PP1 results
in reversed fork degradation in WT cells, in a fashion that is epi-
static with RIF1 inactivation (Fig. 4e, f). Furthermore, RIF1 inac-
tivation results in hyper-phosphorylation of DNA2 upon
replication stress, which again is epistatic with inhibition of PP1
(Fig. 4g). Therefore, one could envision a scenario where access of
DNA2 to stalled forks is ﬁne-tuned through PP1-mediated phos-
phorylation/de-phosphorylation cycles to prevent unrestricted
processing of stalled replication forks.
Importantly, our data also provide insight into the mechanisms
by which reversed fork degradation results in genome instability.
We show that fork degradation upon RIF1 deﬁciency causes
delayed restart, which could be the precursor for subsequent
genome instability (Figs. 5 and 6a). RIF1 has multiple roles in the
maintenance of genome stability, including in the regulation of
origin ﬁring and also in NHEJ. Although disruption of these
processes could also contribute to genome instability, our data
strongly suggest that delayed restart and subsequent exposure of
ssDNA could also contribute to the genome instability upon loss
of RIF1 (Figs. 5 and 6).
Fig. 5 Delayed fork restart and genomic instability observed upon RIF1 deﬁciency. a PFGE analysis for DSBs in WT and Rif1−/− MEFs with and without
treatment with HU for 3 h. WT MEFs treated with IR (15 Gy) was taken as positive control. b Quantiﬁcation of experiment (a), an integration of three
independent experiments showing DSB levels relative to WT untreated (NT), (ns, not-signiﬁcant, from unpaired t-test). c Representative images for
analysis of genomic instability analysis by metaphase spread in WT and Rif1−/− MEFs upon HU and Cisplatin treatment. d Quantitation of chromosomal
aberrations in c. Sixty metaphase ﬁelds per conditions were analyzed and three independent experiments were carried out. P-value was calculated by
unpaired t-test (***P≤ 0.0001). e–f Images for clonogenic survival assay in WT and Rif1−/− MEFs treated with different concentrations of HU (e) and
Cisplatin (f) after which the drugs were washed off and the cells were allowed to grow for 8 days. Adjoining graphs show the data from three independent
experiments. Error bars represent s.e.m. g Schematics of fork restart assay by DNA ﬁbers and representative images for normal restart, delayed restart and
stalled fork upon release from HU treatment. h Quantitation for restart assay in g. Tract lengths of IdU and CldU were quantiﬁed in WT and Rif1−/− MEFs
upon restart after treatment with 1 mM HU for 1 h from 125 ﬁbers per sample. Red and green bars indicate mean CldU and IdU tract length. P-values were
derived from Kruskal–Wallis ANOVA with Benjamini Hochberg post test. All experiments were repeated three times (Supplementary Data 2 and
Supplementary Fig. 8d)
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Restart of reversed forks can take place via multiple non-
mutually exclusive mechanisms. One mechanism includes
helicase-mediated branch migration of the “reversed arm” by
RecQ1 helicase52. However, upon fork degradation, cells can
employ alternate pathways for restart. One such pathway involves
re-priming events ahead of the stalled forks. However, re-priming
can result in gaps in the daughter strands46,53. In line with this
speculation, RIF1-deﬁcient cells accumulate increased ssDNA
gaps behind the forks when allowed to restart after replication
stress. Notably, this phenomenon was dependent on DNA2
activity (Fig. 6c–e). Furthermore, our data indicate that preven-
tion of reversed fork degradation rescues the defective restart in
RIF1-deﬁcient cells (Fig. 6f–h). We propose a model, in which
RIF1 protects reversed forks from degradation and mediates
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efﬁcient restart due to the presence of the reversed arm as sub-
strate for branch migration (Fig. 7a, b). Absence of RIF1 leads to
extensive fork degradation, resulting in delayed restart. This
delayed fork restart results in the exposure of under-replicated
DNA behind the forks (Fig. 7c). The under-replicated DNA then
becomes a source of genome instability later (Fig. 7c).
Identiﬁcation of the mechanisms underlying replication fork
degradation is also clinically relevant, as fork protection in
BRCA-deﬁcient tumors has recently been implicated in
chemoresistance5,6. We speculate that fork degradation at
difﬁcult-to-replicate regions of the genome could be a potential
source of genome instability. Consistent with this idea, RIF1-
deﬁcient cells show a slightly higher background level of genome
instability (Fig. 5a). These low -but tolerable- levels of genome
instability combined with a checkpoint defect could result in
accelerated tumorigenesis. On the other hand, cancers with RIF1
mutations could be more responsive to chemotherapeutic regi-
mens. Although further studies are required to test these
hypotheses, mechanistic insights into the process of replication
fork protection could result in the development of potentially new
therapeutic regimens for cancer.
Methods
Cell culture, cell lines, and transfection reagents. All the MEFs (WT, Rif1−/−,
53bp1−/−, and 53BP115A)30 were cultured in Dulbecco’s Modiﬁed Eagle Medium
(DMEM) supplemented with 10% fetal calf serum (FCS) and 1%
penicillin–streptomycin (PS, P0728 Sigma) at 37 °C and 5% in a humidiﬁed
incubator. Transfections were performed using transfection reagents Xtremegene-9
(Roche) and Lipofectamine-2000 according to the manufacturer’s protocol. WT
and RIF1-KO HAP127 were cultured in Iscove’s Modiﬁed Dulbecco’s Media
(IMDM) containing 10% FCS and 1% pen–strep.
Generation of deletion mutants. RIF1 mutants were created using the standard
PCR and cloning methods. The following primers were used for creating the
deletion mutants for various domains of human RIF1:
hRif-DelCTD-Rev : 5′-GACACAGCGTGTCTGCA-3′
hRif-DelCTD-Fwd : 5′-TAGGACCCAGCTTTCTTGTAC-3′
hRif-DelHEAT- Rev: 5′- CATGGTGAAGCCTGCT-3′
hRif-DelHEAT-Fwd: 5′- CCTGGTTTGGAAACTGTTGAAAT-3′
hRif-DelC1-Fwd: 5′-CAATCTAAGATTTCAGAAATGGCCA-3′
hRif-DelC2-Rev: 5′- GTTCACCAATGGTGGGTAAACA -3′
hRif-DelC2-Fwd: 5′- CTAGAAGAGATTCCAGTTTTTGATATTTCT -3′
The GFP-RIF1 constructs used in this study is based on pcDNA5/FRT/TO-
GFP-RIF1 described previously24, which has human RIF1 cDNA fused to GFP at
its N-terminus. Domain deletions were created using Q5 Mutagenesis Kit (NEB,
cat. No# E0554S), following the manufacturer’s instruction. Primers were used to
PCR amplify the entire plasmid leaving out the region of RIF1 to be deleted. PCR
products were gel puriﬁed and ligated. Introduction of domain deletions were
further veriﬁed by Sanger sequencing.
iPOND-SILAC mass-spectrometry. For SILAC labeling, mouse embryonic cells
(mESCs) were maintained in serum free 2i media deﬁcient in lysine, arginine, and
L-glutamine (PAA) at 37 °C and 5% CO2 in a humidiﬁed incubator. Cells were
grown in medium containing either 73 µg/ml light [12C6]-lysine and 42 µg/ml
[12C6, 14N4]-arginine (Sigma) or similar concentrations of heavy [13C6]-lysine or
[13C6, 15N2]-lysine and or [13C6, 15N4]-lysine arginine (Cambridge Isotope
Laboratories).
For iPOND experiments, cells were labeled with 10 µM EdU for 10 min
and then treated with HU (4 mM) for 2 h to stall the DNA replication forks.
After labeling and treatment cells were washed with Phosphate Buffer Saline
(PBS) and harvested using cell scrapper. Samples were then treated with click
reaction containing 25 µM biotin-azide, 10 mM (+ ) sodium L-ascorbate and 2
mM CuSO4 and rotated at 4 °C for 1 h. Samples were then centrifuged to pellet
down the cells; supernatant was removed and replaced with 1 ml Buffer-1
containing 25 mM NaCl, 2 mM EDTA, 50 mM Tris–HCl, pH 8.0, 1% IGEPAL
and protease inhibitor and rotated again at 4 °C for 30 min This step was
repeated twice. Samples were centrifuged to pellet down the cells; supernatant
was removed and replaced with 500 μl of B1 and sonicated 30 times for 20 s
on and 90 s off at high amplitudes using a Diagenode Bioruptor plus
sonicator. Samples were centrifuged, and supernatant was transferred to fresh
tubes and incubated for 1 h with 200 μl of Dyna-Beads My-One C1 for the
streptavidin biotin capture step. Proteins were eluted, and mass-spectrometry
was performed. At least two peptides were required for protein identiﬁcation.
Quantitation is reported as the log2 of the normalized heavy/light ratios. SILAC
data were analyzed using MaxQuant. The resulting output tables of two
independent experiment were merged and used as the input for calculating the
average fold-change to identify signiﬁcantly upregulated proteins upon HU
treatment based on H:L ratio in the SILAC experiment in the MaxQuant
software54.
Immunoblotting. Cells were lysed in 4x Laemmli sample buffer and boiled for
5 min. Proteins were separated on 4–12% NuPAGE Bis-Tris Gel (Novex life
technologies) and transferred on nitrocellulose membrane (0.45 µM). Mem-
branes were blocked with 5% milk in PBS-1% Tween20 for 1 h and incubated
overnight in primary antibodies. Membranes were then washed three times with
PBS containing 0.05% tween and probed with respective secondary antibodies.
Finally ECL Prime Western Blotting Detection Reagent kit (GE Healthcare) was
used to develop the blots. Details of the antibodies used are provided in Sup-
plementary Table 1.
DNA ﬁber analysis. DNA ﬁber analysis was carried out according to the standard
protocol as mentioned previously18. Brieﬂy, cells were sequentially pulse-labeled
with 30 μM CldU (c6891, Sigma-Aldrich) and 250 μM IdU (I0050000, European
Pharmacopoeia) for 20 min and treated with HU (4 mM) for 3 h for fork degra-
dation assay, and for fork restart assay after ﬁrst labeling with CldU cells were
treated with 1 mM HU for 1 h. After labeling, cells were collected and resuspended
in PBS at 2.5 × 105 cells per ml. The labeled cells were mixed at 1:1 (v/v) with
unlabeled cells, and 2.5 µl of cells were added to 7.5 µl of lysis buffer (200 mM Tris-
HCl, pH 7.5, 50 mM EDTA, and 0.5% (w/v) SDS) on a glass slide. After 8 min, the
slides were tilted at 15–45°, and the resulting DNA spreads were air dried, ﬁxed in
3:1 methanol/acetic acid overnight at 4 °C. The ﬁbers were denatured with 2.5 M
HCl for 1 h, washed with PBS and blocked with 0.2% Tween 20 in 1% BSA/PBS for
40 min The newly replicated CldU and IdU tracks were labeled (for 2.5 h in the
dark, at room temperature (RT)) with anti-BrdU antibodies recognizing CldU
(1:500, ab6326; Abcam) and IdU (1:100, B44, 347580; BD), followed by 1 h
incubation with secondary antibodies at RT in the dark: anti–mouse Alexa Fluor
488 (1:300, A11001, Invitrogen) and anti–rat Cy3 (1:150, 712-166-153, Jackson
Immuno-Research Laboratories, Inc.). Fibers were visualized and imaged by
Carl Zeiss Axio Imager D2 microscope using 63X Plan Apo 1.4 NA oil
Fig. 6 Restart defects are a consequence of fork degradation in RIF1-deﬁcient cells. a PFGE in WT and Rif1−/−MEFs with and without treatment with HU for
3 h and 15 h recovery after treatment. b Quantiﬁcation of experiment (a), from three independent experiments showing DSB levels relative to WT
untreated (NT), (ns, not-signiﬁcant, **P= 0.0019, unpaired t-test). c, d Electron micrographs of ssDNA at the fork (c), and behind the fork (d), 30min after
release from HU treatment. White arrows represent ssDNA at the forks and black arrows in d, represent ssDNA gaps behind the forks e Analysis of ssDNA
at forks upon restart in WT and Rif1−/− MEFs in presence or absence of DNA2 inhibitor. Red bar represents mean, P-value was derived from
Kruskal–Wallis ANOVA with Benjamini Hochberg post test. f Analysis of internal gaps behind forks upon restart in WT and Rif1−/− MEFs in the presence
or absence of DNA2 inhibitor and HU. Graph represents mean and SD from three independent experiments. Chi-square test of trends was done to assess
signiﬁcance of internal ssDNA gaps between WT and Rif1−/− MEFs (ns, non-signiﬁcant, ****P < 0.0001). Numbers of analyzed molecules are indicated
within parenthesis for e, f. g Top: schematics for restart assay by ﬁbers upon DNA2 inhibition. Bottom: Tract lengths of IdU and CldU were quantiﬁed in
WT and Rif1−/− MEFs upon restart after treatment with 1 mM HU for 1 h in the presence or absence of DNA2i. h Top: schematics for ﬁber restart assay
upon transfection of hRIF1 deletion mutant constructs in Rif1−/− MEFs. Bottom: Quantiﬁcation of IdU tracts in Rif1−/− MEFs upon restart after treatment
with 1 mM HU for 1 h in the presence or absence of hRIF1 deletion constructs. Red and green bars in g and h represents mean CldU and IdU tract length, P-
values were obtained from Kruskal–Wallis ANOVA with Benjamini Hochberg post test for FDR. All experiments were repeated thrice (Supplementary
Data 2 and Supplementary Fig. 8h–i). i Survival assay in Rif1−/− MEFs complemented with hRIF1-FL, Del-HEAT, Del-CI, Del-CII constructs of hRIF1 and
treated with different concentrations of HU and Cisplatin. Data represented from three independent experiments, error bars represent s.e.m
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immersion objective. Data analysis was carried out with ImageJ software64. The
Mann–Whitney test was applied for statistical analysis using the GraphPad Prism
Software.
Colony survival assay. Colony survival assay was performed according to the
standard protocol as previously mentioned55. WT and Rif1−/− MEFs were
seeded at low dilutions and treated with different replication poisons (HU, CPT,
and Cisplatin) with different concentrations for 4 h. In complementation
experiments, ﬁrst Rif1−/− MEFs were transfected with hRIF deletion constructs
along with full-length (hRIF1-FL, Del-HEAT, Del-CI, and Del-CII). The protein
expression was allowed for 48 h and conﬁrmed by western blotting. In parallel
same cells were plated out at low dilutions and treated with drugs at different
concentrations for 4 h. Post treatment, drug treated medium was washed out and
cells were allowed to grow in complete growth medium for 8 days. The colonies
detected were ﬁxed, stained, and subsequently analyzed with the Gel-counter by
Oxford Optronix and appertaining Software (version 1.1.2.0). The survival was
plotted after combining three independent experiments as the mean surviving
percentage of colonies after drug treatment compared to the mean surviving
colonies from the non-treated samples.
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Fig. 7 Model for role of RIF1 in fork protection and genome stability. a Replication stress in cells results in replication fork reversal to stabilize stalled
replication forks. b Fork reversal results in the recruitment of RIF1 probably through its C-terminal domain, which has cruciform structure binding
properties. Binding of RIF1 to reversed forks stabilizes them by recruitment of PP1, which brings about de-phosphorylation of DNA2 and thereby limits
access of DNA2 nuclease to these forks and prevents fork degradation. This allows for normal restart of reversed forks probably through RECQ1-mediated
branch migration of these reversed forks resulting in prevention of genome instability and cellular viability upon replication stress. c In contrast, absence of
RIF1 results in DNA2-mediated degradation of reversed forks. In the absence of the preferred substrate (four-way junctions), RECQ1 is unable to bind. Forks
are therefore aberrantly restarted which results in exposure of under-replicated DNA in the form of ssDNA gaps behind the forks. These ssDNA gaps
become a source of genome instability and DSBs later during the cell cycle in G2/M phases resulting in sensitivity to replication stress-inducing agents
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Metaphase spreads and chromosomal aberrations. Metaphase spreads were
carried out according to the standard protocol described previously8. Brieﬂy,
exponentially growing cells (50–80 % conﬂuence) were treated with drugs at dif-
ferent concentrations for 4 h. Post treatment, drug treated medium was washed out
and cells were allowed to grow in complete growth medium and exposed with
colcemid for 6 h. Metaphase spreads were prepared, stained by conventional
methods. A minimum 60 metaphase images were using Carl Zeiss Axio Imager D2
microscope using 63x Plan Apo 1.4 NA oil immersion objective and analyzed with
ImageJ software64 for chromosomal aberrations. Experiments were repeated three
times. To determine the differences between conditions are signiﬁcant a two-tailed
t-test was used. P-values < 0.005 (***) and < 0.0005 (****) were considered as
signiﬁcant.
Immunoﬂuorescence. Cells were grown on coverslips at 70–80% conﬂuency. Cells
were labeled with EdU (10 µM) for 15 min to visualize cells in S-phase. After 15
min, cells were washed and incubated in fresh medium containing HU (4mM) for
3 h. After 3 h cells were washed in PBS and ﬁxed in 2% paraformaldehyde in PBS
containing 0.1% Triton-X and permeabilized for 15 min in 0.5% Triton-X in PBS.
Coverslips were washed three times and subsequently stained with RIF1 primary
antibody (1:5000, rabbit) for 1 h at RT. After 1 h, cells were washed with PBS
containing 0.1% Triton-X followed by incubation in secondary antibody con-
jugated to Alexaﬂuor-488 for 1 h at RT. EdU was visualized with a click-it reaction
(click-it EdU imaging kit, Invitrogen) using a 594 nM ﬂuorescent azide according
to the manufacturer’s protocol. Coverslips were washed and incubated with
DAPI (4',6-diamidino-2-phenylindole) for 10 min and mounted with ProLong
Gold antifade reagent (Invitrogen). In experiments using ionizing radiations, cells
were irradiated with (10 Gy) and allowed to recover for 2 h followed by 2% par-
aformaldehyde ﬁxation and immunostaining. Images were obtained using Carl
Zeiss Axio Imager D2 microscope using 63X Plan Apo 1.4 NA oil immersion
objective and analyzed with ImageJ software64. Details of the antibodies are pro-
vided in Supplementary Tables 1 and 2.
Electron microscope analysis. EM analysis was performed according to the
standard protocol38. For DNA extraction, cells were lysed in lysis buffer and
digested at 50 °C in the presence of Proteinase-K for 2 h. The DNA was puriﬁed
using chloroform/isoamyl alcohol and precipitated in isopropanol and given 70%
ethanol wash and resuspended in elution buffer. Isolated genomic DNA was
digested with PvuII HF restriction enzyme for 4 to 5 h. Replication intermediates
were enriched by using QIAGEN G-100 columns (as manufacture’s protocol) and
concentrated by an Amicon size-exclusion column. The benzyldimethylalk-
ylammonium chloride (BAC) method was used to spread the DNA on the water
surface and then loaded on carbon-coated nickel grids and ﬁnally DNA was coated
with platinum using high-vacuum evaporator MED 010 (Bal Tec). Microscopy was
performed with a transmission electron microscope FEI Talos, with 4 K by 4 K
cmos camera. For each experimental condition, at least 70 replication fork inter-
mediates were analyzed per experiment and ImageJ software64 was used to process
analyze the images.
DSB detection by PFGE. DSB detection by PFGE was done as reported pre-
viously18. Brieﬂy, cells were cast into 0.8% agarose plug (2.5 x 105 cells/plug),
digested in lysis buffer (100 mM EDTA, 1% sodium lauryl sarcosine, 0.2% sodium
deoxycholate, 1 mg/ml proteinase-K) at 37 °C for 36–40 h, and washed in 10 mM
Tris-HCl (pH 8.0)–100 mM EDTA. Electrophoresis was performed at 14 °C in
0.9% pulse ﬁeld-certiﬁed agarose (Bio-Rad) using Tris-borate-EDTA buffer in a
Bio-Rad Chef DR III apparatus (9 h, 120°, 5.5 V/cm, and 30- to 18-s switch time;
6 h, 117°, 4.5 V/cm, and 18- to 9-s switch time; and 6 h, 112°, 4 V/cm, and 9- to 5-s
switch time). The gel was stained with ethidium bromide and imaged on Uvidoc-
HD2 Imager. Quantiﬁcation of DSB was carried out using ImageJ software64.
Relative DSB levels were calculated by comparing the results in the treatment
conditions to that of the DSB level observed in untreated controls.
Flow cytometry for cell cycle analysis and detection of RPA. For ﬂow-
cytometric analysis of cell cycle, cells were labeled with EdU for 20 min followed by
ﬁxation for 10 min in 4% formaldehyde/PBS at room temperature. Cells were then
washed with 1% BSA/PBS and permeabilized in 0.5% saponin buffer in 1% BSA/
PBS. Incorporated EdU was labeled according to the manufacturer’s instructions
(#C35002; Invitrogen). Detection of RPA levels were carried out as previously
described56. Brieﬂy, cells were harvested after treatment with 4 mM HU in 1 h and
the mentioned release time points. Pre-extraction was carried out in 0.2% Triton-
X-100/PBS to remove the non-chromatin bound RPA. Cells were then washed with
0.1/BSA/PBS and ﬁxed with 4% Paraformaldehyde. Permeabilization was carried
out as discussed above, followed by staining with anti RPA32/2 antibody (#ab2175,
Abcam) for 1.5 h and subsequent incubation in secondary antibody. In both the
assays, DNA was stained with 1 μg/ml DAPI. Samples were measured in BD LSR
Fortessa and analyzed by FlowJo software v10.5.0. Details of the antibodies are
provided in Supplementary Tables 1 and 2.
Proximity ligation-based assays (PLA). Cells were grown on cover slips until
60–70% conﬂuency. Cells were incubated with EdU (20 μM) for 15 min to
visualize cells in S-phase. After 15 min cells were washed and incubated in fresh
media containing HU (4 mM) for 3 h. After 3 h cells were washed two times with
PBS and ﬁxed with 2% paraformaldehyde for 15 min at room temperature.
Following ﬁxation and washing, cells were next permeabilized by 0.5% Triton-X
in PBS for 15 min at room temperature. After two washes, freshly prepared click
reaction mix (2 mM copper sulfate, 10 µM biotin-azide, and 100 mM sodium
ascorbate in PBS) was added to each samples and incubated in a humidiﬁed
chamber at room temperature for 1 h. After the click reaction, slides were
washed with PBS for 5 min and placed back in humidiﬁed chamber with
blocking buffer (10% goat serum and 0.1% Triton-X-100 in PBS) for 1 h at room
temperature. Slides were incubated with primary antibody at 4 °C overnight in a
humidiﬁed chamber. Mouse anti-biotin was used in conjunction with the
RIF1 antibody. Slides were washed three times with wash buffer A (0.01 M Tris,
0.15 M NaCl, and 0.05% Tween 20, pH 7.4) for 5 min each. Duolink In Situ
PLA probes anti–mouse plus and anti–rabbit minus were diluted 1:5 in blocking
solution (10% goat serum and 0.1% Triton-X-100 in PBS), dispensed onto
slides (30 µl/well), and incubated for 1 h at 37 °C. Slides were again washed three
times with buffer A 5 min each. Ligation mix was prepared by diluting
Duolink ligation stock (1:5) and ligase (1:40) in high-purity water. Slides were
placed back in the humid chamber, and ligation mix was dispensed onto
slides (30 µl/well) and incubated at 37 °C for 30 min Slides were washed in 60 ml
wash buffer A two times for 2 min each. Ampliﬁcation mix was prepared by
diluting Duolink ampliﬁcation stock (1:5) and rolling circle polymerase (1:80) in
high-purity water. Slides were placed back in the humid chamber, and ampli-
ﬁcation mix was dispensed onto slides (30 µl/well) and incubated at 37 °C for
100 min). Slides were washed with wash buffer B solution (0.2 M Tris and 0.1 M
NaCl) three times for 10 min each and one time in 0.01 × diluted wash buffer B
solution for 1 min, coverslips were incubated with DAPI for 5 min and mounted
with ProLong Gold antifade reagent (Invitrogen). Slides were imaged using Zeiss
LSM 700 Axio Imager Z2 confocal microscope and analyzed using ImageJ
software64.
Immunoprecipations. Cytoplasmic and nuclear extracts were prepared using NE-
PER Nuclear and Cytoplasmic extraction kit according to manufacturer’s protocol.
Protein concentrations were determined using BCA kit. Protein samples were
precleared using 20 µl of Protein A Sepharose Fast Flow (PAS) beads (GE
Healthcare) by incubating 30 min at 4 °C. Samples were spun down and super-
natant was collected in fresh tube. Ten percent inputs were taken out and 200 µg of
nuclear proteins were incubated with 2 µg of DNA2 antibody along with respective
IgG control over night 4 °C keeping ﬁnal volume of 500 µl with RIPA buffer (0.01
M Tris-HCl pH 7.5, 0.15 M NaCl, 1% Triton-X-100, 1% NP-40, 0.1% SDS, protease
inhibitor cocktail). Next day, 50 µl of Protein A Sepharose washed beads with
1XPBS+ 0.1% NP40 was added and samples were further incubated for 2 h at 4 °C.
After ﬁnal incubation samples were washed ﬁve times with wash buffer (150 mM
NaCl, 20 mM Tris–HCl (pH 7.5), 0.1% NP-40, 1 mM EDTA, 2.5 mM Sodium
pyrophosphate, protease inhibitor) 500 µl each, and eluted in 2x Laemmli sample
buffer for sodium dodecyl sulfate polyacrylamide gel electrophoresis and
immunoblot.
Plasmid-based DNA repair assays. For determining the HR and NHEJ proﬁ-
ciency in WT and Rif1−/− cells the following plasmids were used: pDRGFP
(Addgene plasmid #26475) and pCBASceI(Addgene plasmid #26477) for HR and
pCVL Trafﬁc Light Reporter1.1(Sce target) (Addgene plasmid #31482) along with
pCBASceI for NHEJ. For measuring and controlling transfection efﬁciency, Turbo-
GFP expressing plasmid (Sigma, MISSION SHC003) and Scrambled plasmid
(Sigma, MISSION SHC002), were used. In all, 2.5 x 105 cells were co-transfected
with 3 μg of plasmid combinations (i.e., 1.5 μg of each plasmid) using Xtremegene-
9 reagent from Roche in six-well dish. Cells were transfected twice at an interval of
24 h. Post 48 h of transfection, cells were harvested and the GFP-positive cells (for
HR) and RFP-positive cells (for NHEJ) were assessed by ﬂow cytometry. Fifty
thousand events were recorded for each sample. Background normalization was
done by using samples co-transfected with scrambled—reporter plasmid and also
scrambled—pCBASceI plasmid. Final percentage of GFP and RFP-positive cells
were calculated based on the transfection efﬁciency of the cells. Each experiment
was independently performed at least thrice.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The iPOND dataset has been deposited in Figshare repository [https://doi.org/10.6084/
m9.ﬁgshare.8242088.v1]. The source data underlying Figs. 3a, 4b, g, 5a, 6a, and
Supplementary Figs. 1b, 2a, b, e, 3c, f, g, 4c, and 6a, c are provided as a Source Data ﬁle. A
reporting summary for this Article is included as Supplementary Information ﬁle.
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